Pfizer's preliminary analysis of its COVID-19 antiviral pill provided very high success rates. Pfizer's CEO has spoken of his company's pill as a "game-changer." Is he right? How might this pill affect the stock prices of Pfizer and its competitors, as well as the broader market?
COVID-19 restrictions have disrupted trade to the greatest extent since WWII, increasing costs for companies, who are passing on those higher expenses to consumers by raising prices. Will higher product prices hurt company profits?